NovoCure Limited (NASDAQ:NVCR)

Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
NVCR Weekly Chart

Old Forum Content for NVCR

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • DrScience: $NVCR And, I thought is was all a dream... DrScience: I'll take Biotech for $600, Alex... Alex: Answer: The Daily Double!! DrScience: I'll wager $810, Alex. Alex: And, the answer is: Novocure's Optune phase 3 trial results. DrScience: (Shaking head) I don't know, Alex. I was asleep at the wheel on this one. Alex: Oh! What's the opposite of an @woodman Bio-turd? ... A correct answer would have been good for a 70% gain.
  • coldevinc: $NVCR People were talking about $24 being good buy points last month. What is everyone thinking now? Watching chart and reading you all.
  • coldevinc: $NVCR coming back nicely
  • mradams0621: ...
    -4.99% $NVCR NovoCure Ltd 26.26 100
    -4.92% $LABD Direxion Shares Ex 38.65 2730
    -4.76% $ANY Sphere 3D Corp 1.30 20000
    -3.85% $PLX Protalix BioTherap 0.75 5430
    -2.20% $GGN GAMCO Global Gold 4.45 8900
    -0.86% $BTX BioTime Inc 3.46 400

  • coldevinc: $NVCR watching for a good entry. Waiting for a PB to mid 24's. Don't think that is going to happen.... ideas???
  • SierraJW: ...
    $NVCR Novocure Ltd 24.00 9.39%
    $NUAN Nuance Communic 18.55 8.80%
    $EBIX Ebix Inc 38.24 8.33%
    $NYMT New York Mortgage. 6.05 8.23%
    $MRNS Marinus Pharmace 5.50 7.84%
    $CMCM Cheetah Mobile In 18.35 6.87%
    $IDI Tiger Media Inc 11.00 6.49%
    $TJX Tjx Cos. ...
  • jetace: $NVCR it has gone above it's day 1 high per Dan's IPO strategy, bought some last week, novel cancer treatment using electric field technology, good results on some of the worst types of cancer
  • jetace: $NVCR another leg up this morning, added to my position
Visit the Trading Forum to join in the discussion.
Stock Price $USD 21.16
Change -0.89%
Volume 887,030

NovoCure Ltd is a commercial stage oncology company. It is engaged in the development, manufacture and commercialization of tumor treating fields for the treatment of solid tumors.

Request Video of NVCR
Already a member? Sign in here.

Earnings

  • November 2nd, 2017 - 2017 Q3 Earnings
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 14 day FREE membership. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 50,100 stock analysis videos
  • Access an ever expanding library (50,100) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 14 day, no questions asked, 100% money back guarantee!